PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

PRESTO Study Investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)'. Together they form a unique fingerprint.

Medicine & Life Sciences